14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 20 Jun 2024

Trading levels for SAVA

Fibonacci Support & Resistance Levels

Level Price
R3 20.53 3.25%
R2 20.24 1.83%
R1 20.07 0.95%
Price 19.88
S1 19.50 -1.89%
S2 19.33 -2.77%
S3 19.05 -4.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 23.33 17.35%
R2 22.75 14.44%
R1 20.01 0.654%
Price 19.88
S1 19.71 -0.86%
S2 19.64 -1.21%
S3 19.63 -1.26%

SAVA Predictions History

2 years ago
arenter365.247328 predicted that SAVA for 2021-09-15 is going $41.79 (-4.85%)

Rank:

2 years ago
AlexVel predicted that SAVA for 2021-09-08 is going $45.89 (-1.29%)

2 years ago
JS predicted that SAVA for 2021-09-03 is going $57.64 (14.82%)

2 years ago
davedammitt.248165 predicted that SAVA for 2021-09-03 is going

Rank:

2 years ago
RamboRex3000 predicted that SAVA for 2021-08-30 is going $54.72 (2.74%)

2 years ago
AlexVel predicted that SAVA for 2021-08-30 is going $56.42 (5.93%)

2 years ago
JS predicted that SAVA for 2021-08-30 is going $58.34 (9.54%)

2 years ago
Rybkarybka predicted that SAVA for 2021-08-30 is going $62.62 (7.34%)

2 years ago
devilchess.255059 predicted that SAVA for 2021-08-30 is going $58.34 (0.00%)

Rank:

2 years ago
RamboRex3000 predicted that SAVA for 2021-08-26 is going $81.69 (15.30%)

Click to get the best stock tips daily for free!

About Cassava Sciences Inc.

Cassava Sciences Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci... SAVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT